BRD7, a Tumor Suppressor, Interacts with p85α and Regulates PI3K Activity

Molecular Cell

Volumn 54, Issue 1, 2014, Pages 193-202

  Chiu, Yu Hsin ^a,b   Lee, Jennifer Y ^a,b   Cantley, Lewis C ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BROMODOMAIN CONTAINING PROTEIN 7; HETERODIMER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; PROTEIN P53; PROTEIN P85; PROTEIN P85 ALPHA; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; P85 ALPHA; PROTEIN KINASE B; PROTEIN SH2;

ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STEADY STATE; CARBOXY TERMINAL SEQUENCE; EMBRYO; ENZYME REGULATION; GENE TRANSLOCATION; NEGATIVE FEEDBACK; RNA INTERFERENCE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CERCOPITHECUS AETHIOPS; CHO CELLS; CHROMOSOMAL PROTEINS, NON-HISTONE; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; COS CELLS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; HEK293 CELLS; HELA CELLS; HUMANS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84898040266     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.02.016     Document Type: Article

References (33)

1. Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehár J., Kryukov G.V., Sonkin D., et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012, 483:603-607.
2. Bavelloni A., Santi S., Sirri A., Riccio M., Faenza I., Zini N., Cecchi S., Ferri A., Auron P., Maraldi N.M., Marmiroli S. Phosphatidylinositol 3-kinase translocation to the nucleus is induced by interleukin 1 and prevented by mutation of interleukin 1 receptor in human osteosarcoma Saos-2 cells. J.Cell Sci. 1999, 112:631-640.
3. Burrows A.E., Smogorzewska A., Elledge S.J. Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence. Proc. Natl. Acad. Sci. USA 2010, 107:14280-14285.
4. Carpenter C.L., Duckworth B.C., Auger K.R., Cohen B., Schaffhausen B.S., Cantley L.C. Purification and characterization of phosphoinositide 3-kinase from rat liver. J.Biol. Chem. 1990, 265:19704-19711.
5. Chagpar R.B., Links P.H., Pastor M.C., Furber L.A., Hawrysh A.D., Chamberlain M.D., Anderson D.H. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 2010, 107:5471-5476.
6. Cheung L.W., Hennessy B.T., Li J., Yu S., Myers A.P., Djordjevic B., Lu Y., Stemke-Hale K., Dyer M.D., Zhang F., et al. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. Cancer Discov 2011, 1:170-185.
7. Comb W.C., Hutti J.E., Cogswell P., Cantley L.C., Baldwin A.S. p85α SH2 domain phosphorylation by IKK promotes feedback inhibition of PI3K and Akt in response to cellular starvation. Mol. Cell 2012, 45:719-730.
8. Drost J., Mantovani F., Tocco F., Elkon R., Comel A., Holstege H., Kerkhoven R., Jonkers J., Voorhoeve P.M., Agami R., Del Sal G. BRD7 is a candidate tumour suppressor gene required for p53 function. Nat. Cell Biol. 2010, 12:380-389.
9. Filippakopoulos P., Knapp S. The bromodomain interaction module. FEBS Lett. 2012, 586:2692-2704.
10. Fruman D.A. Regulatory subunits of class IA PI3K. Curr. Top. Microbiol. Immunol. 2010, 346:225-244.
11. Fruman D.A., Meyers R.E., Cantley L.C. Phosphoinositide kinases. Annu. Rev. Biochem. 1998, 67:481-507.
12. Fry M.J., Panayotou G., Dhand R., Ruiz-Larrea F., Gout I., Nguyen O., Courtneidge S.A., Waterfield M.D. Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns. Biochem. J. 1992, 288:383-393.
13. Harte M.T., O'Brien G.J., Ryan N.M., Gorski J.J., Savage K.I., Crawford N.T., Mullan P.B., Harkin D.P. BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res. 2010, 70:2538-2547.
14. Huang C.H., Mandelker D., Schmidt-Kittler O., Samuels Y., Velculescu V.E., Kinzler K.W., Vogelstein B., Gabelli S.B., Amzel L.M. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science 2007, 318:1744-1748.
15. Jaiswal B.S., Janakiraman V., Kljavin N.M., Chaudhuri S., Stern H.M., Wang W., Kan Z., Dbouk H.A., Peters B.A., Waring P., et al. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell 2009, 16:463-474.
16. Kaeser M.D., Aslanian A., Dong M.Q., Yates J.R., Emerson B.M. BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J.Biol. Chem. 2008, 283:32254-32263.
17. Lee J.Y., Chiu Y.H., Asara J., Cantley L.C. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains. Proc. Natl. Acad. Sci. USA 2011, 108:14157-14162.
18. Luo J., Field S.J., Lee J.Y., Engelman J.A., Cantley L.C. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J.Cell Biol. 2005, 170:455-464.
19. Mandelker D., Gabelli S.B., Schmidt-Kittler O., Zhu J., Cheong I., Huang C.H., Kinzler K.W., Vogelstein B., Amzel L.M. A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane. Proc. Natl. Acad. Sci. USA 2009, 106:16996-17001.
20. Martelli A.M., Borgatti P., Bortul R., Manfredini M., Massari L., Capitani S., Neri L.M. Phosphatidylinositol 3-kinase translocates to the nucleus of osteoblast-like MC3T3-E1 cells in response to insulin-like growth factor I and platelet-derived growth factor but not to the proapoptotic cytokine tumor necrosis factor alpha. J.Bone Miner. Res. 2000, 15:1716-1730.
21. Neri L.M., Milani D., Bertolaso L., Stroscio M., Bertagnolo V., Capitani S. Nuclear translocation of phosphatidylinositol 3-kinase in rat pheochromocytoma PC 12 cells after treatment with nerve growth factor. Cell. Mol. Biol. (Noisy-le-grand) 1994, 40:619-626.
22. Park S.W., Zhou Y., Lee J., Lu A., Sun C., Chung J., Ueki K., Ozcan U. The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat. Med. 2010, 16:429-437.
23. Quayle S.N., Lee J.Y., Cheung L.W., Ding L., Wiedemeyer R., Dewan R.W., Huang-Hobbs E., Zhuang L., Wilson R.K., Ligon K.L., et al. Somatic mutations of PIK3R1 promote gliomagenesis. PLoS ONE 2012, 7:e49466.
24. Rabinovsky R., Pochanard P., McNear C., Brachmann S.M., Duke-Cohan J.S., Garraway L.A., Sellers W.R. p85 Associates with unphosphorylated PTEN and the PTEN-associated complex. Mol. Cell. Biol. 2009, 29:5377-5388.
25. Song L., Gao M., Dong W., Hu M., Li J., Shi X., Hao Y., Li Y., Huang C. p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response. Oncogene 2011, 30:1360-1371.
26. Taniguchi C.M., Tran T.T., Kondo T., Luo J., Ueki K., Cantley L.C., Kahn C.R. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proc. Natl. Acad. Sci. USA 2006, 103:12093-12097.
27. Taniguchi C.M., Aleman J.O., Ueki K., Luo J., Asano T., Kaneto H., Stephanopoulos G., Cantley L.C., Kahn C.R. The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Mol. Cell. Biol. 2007, 27:2830-2840.
28. Taniguchi C.M., Winnay J., Kondo T., Bronson R.T., Guimaraes A.R., Alemán J.O., Luo J., Stephanopoulos G., Weissleder R., Cantley L.C., Kahn C.R. The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer Res. 2010, 70:5305-5315.
29. Ueki K., Fruman D.A., Yballe C.M., Fasshauer M., Klein J., Asano T., Cantley L.C., Kahn C.R. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J.Biol. Chem. 2003, 278:48453-48466.
30. Wu W.J., Hu K.S., Chen D.L., Zeng Z.L., Luo H.Y., Wang F., Wang D.S., Wang Z.Q., He F., Xu R.H. Prognostic relevance of BRD7 expression in colorectal carcinoma. Eur. J. Clin. Invest. 2013, 43:131-140.
31. Yin Y., Terauchi Y., Solomon G.G., Aizawa S., Rangarajan P.N., Yazaki Y., Kadowaki T., Barrett J.C. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 1998, 391:707-710.
32. Yu J., Zhang Y., McIlroy J., Rordorf-Nikolic T., Orr G.A., Backer J.M. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol. Cell. Biol. 1998, 18:1379-1387.
33. Zhou J., Ma J., Zhang B.C., Li X.L., Shen S.R., Zhu S.G., Xiong W., Liu H.Y., Huang H., Zhou M., Li G.Y. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways. J.Cell. Physiol. 2004, 200:89-98.